In summary, although the TWEAK/Fn14 signaling axis appears to be a promising therapeutic target for multiple cancer types, more studies are warranted in order to understand the full spectrum of TWEAK-mediated pro- and anti-cancer cell effects. The gene discussed is TNFSF12; the disease is cancer.